Prima Biomed to Receive Undisclosed Milestone Payment from Novartis

By: via Benzinga
Prima BioMed Ltd (NASDAQ: PBMD)today announced it will receive an undisclosed clinical milestone payment from its collaboration and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.